Article
Computational repurposing of oncology drugs through off-target drug binding interactions from pharmacological databases
2023-07-01
Abstract excerpt
<h4>PURPOSE</h4> Systematic repurposing of approved medicine for another indication represents an attractive strategy to accelerating drug development in oncology. Herein we present a strategy of combining biomarker testing with drug repurposing to identify new treatments for patients with advanced cancer. <h4>METHODS</h4> Tumours were sequenced with Illumina TruSight Oncology 500 (TSO-500) platform or the Found...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 680a273a-52af-5457-bc64-38c8e4a2f027
- DOI
- 10.1101/2023.07.01.547311
